WHO ICTRP trial
evaluation of highsense barij effectiveness
IRCT20130722014106N8 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20130722014106N8 |
|---|---|
| Public title | evaluation of highsense barij effectiveness |
| Scientific title | The effect of highsense barij containinig Tribulus Terrestris extract, Panax ginseng and L-arginine on male libido and comparing with placebo |
| Primary sponsor | Kermanshah University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | erectile dysfunction. Male erectile dysfunction |
| Interventions | Intervention 1: Intervention group: Drug receiving group :500 mg Highsense Barij tablets made by Barij Essence Pharmaceutical Company containing ginseng, Tribulus terrestris extract and L-arginine standardized containing 100 mg of total… |
| Registration date | Dec 17, 2020 |
| Target size | 34 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: